ESC 365 - Post-TAVR antithrombotic treatment and one-year survival: insights from the FRANCE TAVI registry

ESC Premium Access

Post-TAVR antithrombotic treatment and one-year survival: insights from the FRANCE TAVI registry

Session: Young Investigator Award Session Valvular Heart Disease

Topic: Aortic Valve Intervention

Speaker: Mr P. Overtchouk (Bern, CH)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Pavel Overtchouk

Bern University Hospital, Inselspital, Bern (Switzerland)

1 presentation

1 follower

3 more presentations in this session

Long-term follow-up in the German TRAnscatheter mitral valve Interventions (TRAMI) registry: survival and predictors of mortality

Speaker: Doctor D. Kalbacher (Hamburg, DE)

18F-Fluoride PET-CT in the detection of early bioprosthetic valve degeneration

Speaker: Doctor T. Cartlidge (Newcastle-Upon-Tyne, GB)

Long-term risk of infective endocarditis following transcatheter aortic valve implantation: a nationwide cohort study

Speaker: Doctor J. Butt (Copenhagen, DK)

Access the full session

Young Investigator Award Session Valvular Heart Disease

Speakers: Mr P. Overtchouk, Doctor D. Kalbacher, Doctor T. Cartlidge, Doctor J. Butt

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources